For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Vanda Pharmaceuticals Inc’s stock clocked out at $5.11, down -0.39% from its previous closing price of $5.13. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 0.57 million shares were traded. VNDA stock price reached its highest trading level at $5.22 during the session, while it also had its lowest trading level at $5.0648.
Ratios:
To gain a deeper understanding of VNDA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.68. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On February 25, 2022, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $24 to $12.
On May 12, 2021, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.BofA Securities initiated its Buy rating on May 12, 2021, with a $22 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 29 ’24 when Moran Kevin Patrick bought 2,251 shares for $5.92 per share.
Moran Kevin Patrick sold 2,251 shares of VNDA for $13,327 on Jul 29 ’24. The SVP, CFO & Treasurer now owns 228,763 shares after completing the transaction at $5.92 per share. On Mar 05 ’24, another insider, Polymeropoulos Mihael Hristos, who serves as the President and CEO of the company, sold 24,288 shares for $4.13 each. As a result, the insider received 100,273 and left with 1,871,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 297860896 and an Enterprise Value of -81384080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.64 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at -0.447 whereas that against EBITDA is 3.066.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.30. The 50-Day Moving Average of the stock is -11.47%, while the 200-Day Moving Average is calculated to be 11.04%.
Shares Statistics:
It appears that VNDA traded 1.02M shares on average per day over the past three months and 662170 shares per day over the past ten days. A total of 57.53M shares are outstanding, with a floating share count of 55.19M. Insiders hold about 5.32% of the company’s shares, while institutions hold 84.35% stake in the company. Shares short for VNDA as of 1722384000 were 2782119 with a Short Ratio of 2.72, compared to 1719532800 on 2864195. Therefore, it implies a Short% of Shares Outstanding of 2782119 and a Short% of Float of 5.7700000000000005.
